Detalles de la búsqueda
1.
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 22(11): 1573-1581, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656225
2.
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
Oncologist
; 26(1): e164-e172, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017510
3.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 26(2): 139-146, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145877
4.
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 21(2): 250-260, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859246
5.
U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.
Oncologist
; 24(5): e188-e195, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31019020
6.
U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.
Oncologist
; 20(11): 1320-5, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26446239
7.
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 30(10): 2011-2016, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441576
8.
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 42(15): 1851-1860, 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452327
9.
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 42(5): 605-613, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127780
10.
Regulatory implications of ctDNA in immuno-oncology for solid tumors.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36796877
11.
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer.
J Clin Oncol
; 41(11): 2108-2116, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780610
12.
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 29(24): 5008-5011, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594723
13.
A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(4): 373-378, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271635
14.
Inferring species-level phylogenies and taxonomic distinctiveness using multilocus data in Sistrurus rattlesnakes.
Syst Biol
; 60(4): 393-409, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21389297
15.
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer.
J Clin Oncol
; 40(11): 1155-1162, 2022 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35084948
16.
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Clin Cancer Res
; 28(22): 4843-4848, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727604
17.
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.
Clin Cancer Res
; 28(6): 1058-1071, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711631
18.
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.
Clin Cancer Res
; 28(6): 1072-1086, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711632
19.
Unifying vertical and nonvertical evolution: a stochastic ARG-based framework.
Syst Biol
; 59(1): 27-41, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525618
20.
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.
Clin Cancer Res
; 27(8): 2126-2129, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188141